Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer

Advances in Cancer Research

Volumn 127, Issue , 2015, Pages 1-47

  Li, Da Qiang ^a,b   Kumar, Rakesh ^c,d,e  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Gene transcription; Metastasis associated gene; NuRD complex

Indexed keywords

BETA ELEMENE; CURCUMIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GENISTEIN; GROWTH FACTOR; METASTASIS ASSOCIATED PROTEIN 1; MICRORNA; NATURAL PRODUCT; NURD PROTEIN; PEPTIDE; PORTULACEREBROSIDE A; PROTEIN; PTEROSTILBENE; RESVERATROL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HISTONE DEACETYLASE; MTA1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

CELL STRESS; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MOUTH CANCER; NASOPHARYNX CANCER; NEOPLASM; NON SMALL CELL LUNG CANCER; NUCLEOSOME; OSTEOSARCOMA; OVARY CANCER; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS ISLET CELL TUMOR; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; STOMACH CANCER; THYMOMA; TONSIL CANCER; GENETICS; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION;

GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; NEOPLASMS; PROGNOSIS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84945460772     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.acr.2015.04.005     Document Type: Chapter

References (228)

1. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Nature Reviews. Molecular Cell Biology 2005, 6:635-645.
2. Akhurst R.J., Hata A. Targeting the TGFbeta signalling pathway in disease. Nature Reviews Drug Discovery 2012, 11:790-811.
3. Andishehtadbir A., Najvani A.D., Pardis S., Ashkavandi Z.J., Ashraf M.J., Khademi B., et al. Metastasis-associated protein 1 expression in oral squamous cell carcinomas: correlation with metastasis and angiogenesis. Turk Patoloji Derg 2015, 31:9-15.
4. Au T.J., Rodriguez J., Vincent J.A., Tsukiyama T. ATP-dependent chromatin remodeling factors tune S phase checkpoint activity. Molecular and Cellular Biology 2011, 31:4454-4463.
5. Ayrapetov M.K., Xu C., Sun Y., Zhu K., Parmar K., D'Andrea A.D., et al. Activation of Hif1alpha by the prolylhydroxylase inhibitor dimethyoxalyglycine decreases radiosensitivity. PloS One 2011, 6:e26064.
6. Badenhorst P., Voas M., Rebay I., Wu C. Biological functions of the ISWI chromatin remodeling complex NURF. Genes & Development 2002, 16:3186-3198.
7. Balasenthil S., Broaddus R.R., Kumar R. Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Human Pathology 2006, 37:656-661.
8. Balasenthil S., Gururaj A.E., Talukder A.H., Bagheri-Yarmand R., Arrington T., Haas B.J., et al. Identification of Pax5 as a target of MTA1 in B-cell lymphomas. Cancer Research 2007, 67:7132-7138.
9. Bao Y., Shen X. SnapShot: Chromatin remodeling complexes. Cell 2007, 129:632.
10. Barone I., Brusco L., Gu G., Selever J., Beyer A., Covington K.R., et al. Loss of Rho GDIalpha and resistance to tamoxifen via effects on estrogen receptor alpha. Journal of the National Cancer Institute 2011, 103:538-552.
11. Bassi C., Ho J., Srikumar T., Dowling R.J., Gorrini C., Miller S.J., et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 2013, 341:395-399.
12. Bieging K.T., Mello S.S., Attardi L.D. Unravelling mechanisms of p53-mediated tumour suppression. Nature Reviews Cancer 2014, 14:359-370.
13. Bowen N.J., Fujita N., Kajita M., Wade P.A. Mi-2/NuRD: Multiple complexes for many purposes. Biochimica et Biophysica Acta 2004, 1677:52-57.
14. Bruning A., Juckstock J., Blankenstein T., Makovitzky J., Kunze S., Mylonas I. The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas. Histology and Histopathology 2010, 25:1447-1456.
15. Bui-Nguyen T.M., Pakala S.B., Sirigiri D.R., Martin E., Murad F., Kumar R. Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. The Journal of Biological Chemistry 2010, 285:6980-6986.
16. Bui-Nguyen T.M., Pakala S.B., Sirigiri R.D., Xia W., Hung M.C., Sarin S.K., et al. NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene 2010, 29:1179-1189.
17. Cairns B.R. The logic of chromatin architecture and remodelling at promoters. Nature 2009, 461:193-198.
18. Chen D.W., Fan Y.F., Li J., Jiang X.X. MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma. Tumour Biology: The journal of the International Society for Oncodevelopmental Biology and Medicine 2013, 34:1553-1557.
19. Chen Z., Han M. Role of C. elegans lin-40 MTA in vulval fate specification and morphogenesis. Development 2001, 128:4911-4921.
20. Chen X., Wang Y., Luo H., Luo Z., Zhang T., Yang N., et al. beta-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1. Molecular Medicine Reports 2012, 6:989-995.
21. Cheng C.W., Liu Y.F., Yu J.C., Wang H.W., Ding S.L., Hsiung C.N., et al. Prognostic significance of cyclin D1, beta-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast. Annals of Surgical Oncology 2012, 19:4129-4139.
22. Chou D.M., Adamson B., Dephoure N.E., Tan X., Nottke A.C., Hurov K.E., et al. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:18475-18480.
23. Chu H., Chen X., Wang H., Du Y., Wang Y., Zang W., et al. MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3. Tumour Biology: The journal of the International Society for Oncodevelopmental Biology and Medicine 2014, 35:3487-3494.
24. Cimen I., Tuncay S., Banerjee S. 15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29. Cancer Science 2009, 100:2283-2291.
25. Cong L., Pakala S.B., Ohshiro K., Li D.Q., Kumar R. SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function. The Journal of Biological Chemistry 2011, 286:43793-43808.
26. Covington K.R., Brusco L., Barone I., Tsimelzon A., Selever J., Corona-Rodriguez A., et al. Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer. Breast Cancer Research and Treatment 2013, 141:375-384.
27. Cui Y., Niu A., Pestell R., Kumar R., Curran E.M., Liu Y., et al. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Molecular Endocrinology 2006, 20:2020-2035.
28. Dannenmann C., Shabani N., Friese K., Jeschke U., Mylonas I., Bruning A. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biology & Therapy 2008, 7:1460-1467.
29. Deng X., Du L., Wang C., Yang Y., Li J., Liu H., et al. Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer. World Journal of Surgery 2013, 37:792-798.
30. Deng Y.F., Zhou D.N., Ye C.S., Zeng L., Yin P. Aberrant expression levels of MTA1 and RECK in nasopharyngeal carcinoma: Association with metastasis, recurrence, and prognosis. The Annals of Otology, Rhinology, and Laryngology 2012, 121:457-465.
31. Dhar S., Kumar A., Li K., Tzivion G., Levenson A.S. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochimica et Biophysica Acta 2014, 1853:265-275.
32. Dias S.J., Zhou X., Ivanovic M., Gailey M.P., Dhar S., Zhang L., et al. Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans. Scientific Reports 2013, 3:2331.
33. Ding Z., Gillespie L.L., Paterno G.D. Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain. Molecular and Cellular Biology 2003, 23:250-258.
34. Dong H., Guo H., Xie L., Wang G., Zhong X., Khoury T., et al. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma. PloS One 2013, 8:e62986.
35. Du B., Yang Z.Y., Zhong X.Y., Fang M., Yan Y.R., Qi G.L., et al. Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World Journal of Gastroenterology: WJG 2011, 17:1219-1226.
36. El Marzouk S., Schultz-Norton J.R., Likhite V.S., McLeod I.X., Yates J.R., Nardulli A.M. Rho GDP dissociation inhibitor alpha interacts with estrogen receptor alpha and influences estrogen responsiveness. Journal of Molecular Endocrinology 2007, 39:249-259.
37. Ellis L.M., Hicklin D.J. VEGF-targeted therapy: Mechanisms of anti-tumour activity. Nature Reviews Cancer 2008, 8:579-591.
38. Euskirchen G., Auerbach R.K., Snyder M. SWI/SNF chromatin-remodeling factors: Multiscale analyses and diverse functions. Journal of Biological Chemistry 2012, 287:30897-30905.
39. Faiola F., Liu X., Lo S., Pan S., Zhang K., Lymar E., et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Molecular and Cellular Biology 2005, 25:10220-10234.
40. Fan L., Wang H., Xia X., Rao Y., Ma X., Ma D., et al. Loss of E-cadherin promotes prostate cancer metastasis via upregulation of metastasis-associated gene 1 expression. Oncology Letters 2012, 4:1225-1233.
41. Feng X., Zhang Q., Xia S., Xia B., Zhang Y., Deng X., et al. MTA1 overexpression induces cisplatin resistance in nasopharyngeal carcinoma by promoting cancer stem cells properties. Molecules and Cells 2014, 37:699-704.
42. Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., Wade P.A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003, 113:207-219.
43. Fujita N., Kajita M., Taysavang P., Wade P.A. Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Molecular Endocrinology 2004, 18:2937-2949.
44. Futamura M., Nishimori H., Shiratsuchi T., Saji S., Nakamura Y., Tokino T. Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1. Journal of Human Genetics 1999, 44:52-56.
45. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: Rationale, strategies and challenges. Nature Reviews Drug Discovery 2010, 9:775-789.
46. Ghanta K.S., Pakala S.B., Reddy S.D., Li D.Q., Nair S.S., Kumar R. MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response. The Journal of Biological Chemistry 2011, 286:7132-7138.
47. Gururaj A.E., Holm C., Landberg G., Kumar R. Breast cancer-amplified sequence 3, a target of metastasis-associated protein 1, contributes to tamoxifen resistance in premenopausal patients with breast cancer. Cell Cycle 2006, 5:1407-1410.
48. Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P., Zhang H., et al. MTA1, a transcriptional activator of breast cancer amplified sequence 3. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6670-6675.
49. Hall J.A., Georgel P.T. CHD proteins: A diverse family with strong ties. Biochemistry and Cell Biology (Biochimie et Biologie Cellulaire) 2007, 85:463-476.
50. Hamatsu T., Rikimaru T., Yamashita Y., Aishima S., Tanaka S., Shirabe K., et al. The role of MTA1 gene expression in human hepatocellular carcinoma. Oncology Reports 2003, 10:599-604.
51. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
52. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell 2011, 144:646-674.
53. Higashijima J., Kurita N., Miyatani T., Yoshikawa K., Morimoto S., Nishioka M., et al. Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer. Oncology Reports 2011, 26:343-348.
54. Hofer M.D., Chang M.C., Hirko K.A., Rubin M.A., Nose V. Immunohistochemical and clinicopathological correlation of the metastasis-associated gene 1 (MTA1) expression in benign and malignant pancreatic endocrine tumors. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc 2009, 22:933-939.
55. Hofer M.D., Kuefer R., Varambally S., Li H., Ma J., Shapiro G.I., et al. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Research 2004, 64:825-829.
56. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science 1991, 253:49-53.
57. Jang K.S., Paik S.S., Chung H., Oh Y.H., Kong G. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Science 2006, 97:374-379.
58. Ji Q., Zheng G.Y., Xia W., Chen J.Y., Meng X.Y., Zhang H., et al. Inhibition of invasion and metastasis of human liver cancer HCCLM3 cells by portulacerebroside A. Pharmaceutical Biology 2014, 1-8.
59. Johnstone R.W. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nature Reviews Drug Discovery 2002, 1:287-299.
60. Kai L., Samuel S.K., Levenson A.S. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. International Journal of Cancer. Journal International du Cancer 2010, 126:1538-1548.
61. Kai L., Wang J., Ivanovic M., Chung Y.T., Laskin W.B., Schulze-Hoepfner F., et al. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). The Prostate 2011, 71:268-280.
62. Kaller M., Liffers S.T., Oeljeklaus S., Kuhlmann K., Roh S., Hoffmann R., et al. Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Molecular & Cellular Proteomics: MCP 2011, 10(M111):010462.
63. Kang H., Kiess A., Chung C.H. Emerging biomarkers in head and neck cancer in the era of genomics. Nature Reviews. Clinical Oncology 2015, 12:11-26.
64. Kang H.J., Lee M.H., Kang H.L., Kim S.H., Ahn J.R., Na H., et al. Differential regulation of estrogen receptor alpha expression in breast cancer cells by metastasis-associated protein 1. Cancer Research 2014, 74:1484-1494.
65. Kaur E., Gupta S., Dutt S. Clinical implications of MTA proteins in human cancer. Cancer Metastasis Reviews 2014, 33:1017-1024.
66. Kawasaki G., Yanamoto S., Yoshitomi I., Yamada S., Mizuno A. Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: Correlation with metastasis and invasion. International Journal of Oral and Maxillofacial Surgery 2008, 37:1039-1046.
67. Khaleque M.A., Bharti A., Gong J., Gray P.J., Sachdev V., Ciocca D.R., et al. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 2008, 27:1886-1893.
68. Kleene R., Zdzieblo J., Wege K., Kern H.F. A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are differentially expressed by alternative transcription initiation in pancreatic acinar cells of the rat. Journal of Cell Science 1999, 112(Pt 15):2539-2548.
69. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Research 2001, 29:2905-2919.
70. Kong X., Xu X., Yan Y., Guo F., Li J., Hu Y., et al. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PloS One 2014, 9:e90810.
71. Kumar R., Balasenthil S., Manavathi B., Rayala S.K., Pakala S.B. Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor. Cancer Research 2010, 70:6649-6658.
72. Kumar R., Balasenthil S., Pakala S.B., Rayala S.K., Sahin A.A., Ohshiro K. Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells. Cancer Research 2010, 70:6598-6608.
73. Kumar R., Wang R.A., Bagheri-Yarmand R. Emerging roles of MTA family members in human cancers. Seminars in Oncology 2003, 30:30-37.
74. Kumar R., Wang R.A., Mazumdar A., Talukder A.H., Mandal M., Yang Z., et al. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature 2002, 418:654-657.
75. Kuo A.J., Song J., Cheung P., Ishibe-Murakami S., Yamazoe S., Chen J.K., et al. The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome. Nature 2012, 484:115-119.
76. Lai A.Y., Wade P.A. Cancer biology and NuRD: A multifaceted chromatin remodelling complex. Nature Reviews Cancer 2011, 11:588-596.
77. Lee M.H., Na H., Kim E.J., Lee H.W., Lee M.O. Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1. Oncogene 2012, 31:5099-5107.
78. Lee M.H., Na H., Na T.Y., Shin Y.K., Seong J.K., Lee M.O. Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis. Oncogenesis 2012, 1:e25.
79. Lee M.H., Na H., Na T.Y., Shin Y.K., Seong J.K., Lee M.O. Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis. Oncogenesis 2014, 3:e88.
80. Lee H., Ryu S.H., Hong S.S., Seo D.D., Min H.J., Jang M.K., et al. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation. Journal of Gastroenterology and Hepatology 2009, 24:1445-1450.
81. Lewis G.D., Lofgren J.A., McMurtrey A.E., Nuijens A., Fendly B.M., Bauer K.D., et al. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Research 1996, 56:1457-1465.
82. Li W., Bao W., Ma J., Liu X., Xu R., Wang R.A., et al. Metastasis tumor antigen 1 is involved in the resistance to heat stress-induced testicular apoptosis. FEBS Letters 2008, 582:869-873.
83. Li Y., Chao Y., Fang Y., Wang J., Wang M., Zhang H., et al. MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. Journal of Experimental & Clinical Cancer Research: CR 2013, 32:33.
84. Li K., Dias S.J., Rimando A.M., Dhar S., Mizuno C.S., Penman A.D., et al. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PloS One 2013, 8:e57542.
85. Li D.Q., Divijendra Natha Reddy S., Pakala S.B., Wu X., Zhang Y., Rayala S.K., et al. MTA1 coregulator regulates p53 stability and function. The Journal of Biological Chemistry 2009, 284:34545-34552.
86. Li D.Q., Kumar R. Mi-2/NuRD complex making inroads into DNA-damage response pathway. Cell Cycle 2010, 9:2071-2079.
87. Li W.F., Liu N., Cui R.X., He Q.M., Chen M., Jiang N., et al. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma. Journal of Translational Medicine 2012, 10:78.
88. Li D.Q., Ohshiro K., Khan M.N., Kumar R. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function. The Journal of Biological Chemistry 2010, 285:19802-19812.
89. Li D.Q., Ohshiro K., Reddy S.D., Pakala S.B., Lee M.H., Zhang Y., et al. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:17493-17498.
90. Li D.Q., Pakala S.B., Nair S.S., Eswaran J., Kumar R. Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Research 2012, 72:387-394.
91. Li D.Q., Pakala S.B., Reddy S.D., Ohshiro K., Peng S.H., Lian Y., et al. Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. The Journal of Biological Chemistry 2010, 285:10044-10052.
92. Li D.Q., Pakala S.B., Reddy S.D., Ohshiro K., Zhang J.X., Wang L., et al. Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:8791-8796.
93. Li D.Q., Pakala S.B., Reddy S.D., Peng S., Balasenthil S., Deng C.X., et al. Metastasis-associated protein 1 is an integral component of the circadian molecular machinery. Nature Communications 2013, 4:2545.
94. Li Z., Rana T.M. Therapeutic targeting of microRNAs: Current status and future challenges. Nature Reviews Drug Discovery 2014, 13:622-638.
95. Li H., Sun L., Xu Y., Li Z., Luo W., Tang Z., et al. Overexpression of MTA3 correlates with tumor progression in non-small cell lung cancer. PloS One 2013, 8:e66679.
96. Li S.H., Tian H., Yue W.M., Li L., Gao C., Li W.J., et al. Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer. World Journal of Surgery 2012, 36:623-631.
97. Li S.H., Tian H., Yue W.M., Li L., Li W.J., Chen Z.T., et al. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer. Annals of Surgical Oncology 2011, 18:2048-2056.
98. Li Y., Vandenboom T.G., Wang Z., Kong D., Ali S., Philip P.A., et al. miR-146a suppresses invasion of pancreatic cancer cells. Cancer Research 2010, 70:1486-1495.
99. Li S.H., Wang Z., Liu X.Y. Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer. World Journal of Surgery 2009, 33:1876-1881.
100. Li W., Wu Z.Q., Zhao J., Guo S.J., Li Z., Feng X., et al. Transient protection from heat-stress induced apoptotic stimulation by metastasis-associated protein 1 in pachytene spermatocytes. PloS One 2011, 6:e26013.
101. Li D.Q., Yang Y., Kumar R. MTA family of proteins in DNA damage response: Mechanistic insights and potential applications. Cancer Metastasis Reviews 2014, 33:993-1000.
102. Liu S.L., Han Y., Zhang Y., Xie C.Y., Wang E.H., Miao Y., et al. Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer. Targeted Oncology 2012, 7:135-143.
103. Liu X., Li X., Yin L., Ding J., Jin H., Feng Y. Genistein inhibits placental choriocarcinoma cell line JAR invasion through ERbeta/MTA3/Snail/E-cadherin pathway. Oncology Letters 2011, 2:891-897.
104. Liu Y.P., Shan B.E., Wang X.L., Ma L. Correlation between MTA2 overexpression and tumour progression in esophageal squamous cell carcinoma. Experimental and Therapeutic Medicine 2012, 3:745-749.
105. Liu J., Xu D., Wang H., Zhang Y., Chang Y., Zhang J., et al. The subcellular distribution and function of MTA1 in cancer differentiation. Oncotarget 2014, 5:5153-5164.
106. Liu T., Yang M., Yang S., Ge T., Gu L., Lou G. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer. Human Pathology 2013, 44:2275-2281.
107. Lu Y., Wei C., Xi Z. Curcumin suppresses proliferation and invasion in non-small cell lung cancer by modulation of MTA1-mediated Wnt/beta-catenin pathway. In Vitro Cellular & Developmental Biology: Animal 2014, 50:840-850.
108. Luo H., Li H., Yao N., Hu L., He T. Metastasis-associated protein 1 as a new prognostic marker for solid tumors: A meta-analysis of cohort studies. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2014, 35:5823-5832.
109. Luo J., Su F., Chen D., Shiloh A., Gu W. Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000, 408:377-381.
110. Ma L., Li W., Zhu H.P., Li Z., Sun Z.J., Liu X.P., et al. Localization and androgen regulation of metastasis-associated protein 1 in mouse epididymis. PloS One 2010, 5:e15439.
111. Mahoney M.G., Simpson A., Jost M., Noe M., Kari C., Pepe D., et al. Metastasis-associated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 2002, 21:2161-2170.
112. Manavathi B., Kumar R. Metastasis tumor antigens, an emerging family of multifaceted master coregulators. The Journal of Biological Chemistry 2007, 282:1529-1533.
113. Manavathi B., Peng S., Rayala S.K., Talukder A.H., Wang M.H., Wang R.A., et al. Repression of Six3 by a corepressor regulates rhodopsin expression. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:13128-13133.
114. Mann J. Natural products in cancer chemotherapy: Past, present and future. Nature Reviews Cancer 2002, 2:143-148.
115. Mao X.Y., Chen H., Wang H., Wei J., Liu C., Zheng H.C., et al. MTA1 expression correlates significantly with ER-alpha methylation in breast cancer. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine 2012, 33:1565-1572.
116. Marks P., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer: Causes and therapies. Nature Reviews Cancer 2001, 1:194-202.
117. Martin M.D., Fischbach K., Osborne C.K., Mohsin S.K., Allred D.C., O'Connell P. Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene. Cancer Research 2001, 61:3578-3580.
118. Martin M.D., Hilsenbeck S.G., Mohsin S.K., Hopp T.A., Clark G.M., Osborne C.K., et al. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Research and Treatment 2006, 95:7-12.
119. Martinez-Balbas M.A., Tsukiyama T., Gdula D., Wu C. Drosophila NURF-55, a WD repeat protein involved in histone metabolism. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:132-137.
120. Marzook H., Deivendran S., Kumar R., Pillai M.R. Role of MTA1 in head and neck cancers. Cancer and Metastasis Reviews 2014, 33(4):953-964.
121. Mazumdar A., Wang R.A., Mishra S.K., Adam L., Bagheri-Yarmand R., Mandal M., et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Biology 2001, 3:30-37.
122. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437:436-439.
123. Millard C.J., Watson P.J., Celardo I., Gordiyenko Y., Cowley S.M., Robinson C.V., et al. Class I HDACs share a common mechanism of regulation by inositol phosphates. Molecular Cell 2013, 51:57-67.
124. Mishra S.K., Mazumdar A., Vadlamudi R.K., Li F., Wang R.A., Yu W., et al. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. The Journal of Biological Chemistry 2003, 278:19209-19219.
125. Mishra S.K., Talukder A.H., Gururaj A.E., Yang Z., Singh R.R., Mahoney M.G., et al. Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway. The Journal of Biological Chemistry 2004, 279:32709-32715.
126. Mishra S.K., Yang Z., Mazumdar A., Talukder A.H., Larose L., Kumar R. Metastatic tumor antigen 1 short form (MTA1s) associates with casein kinase I-gamma2, an estrogen-responsive kinase. Oncogene 2004, 23:4422-4429.
127. Miyake K., Yoshizumi T., Imura S., Sugimoto K., Batmunkh E., Kanemura H., et al. Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: Correlation with poor prognosis with possible regulation. Pancreas 2008, 36:e1-e9.
128. Mizuguchi G., Tsukiyama T., Wisniewski J., Wu C. Role of nucleosome remodeling factor NURF in transcriptional activation of chromatin. Molecular Cell 1997, 1:141-150.
129. Molli P.R., Singh R.R., Lee S.W., Kumar R. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene. Oncogene 2008, 27:1971-1980.
130. Moon W.S., Chang K., Tarnawski A.S. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: Relationship to vascular invasion and estrogen receptor-alpha. Human Pathology 2004, 35:424-429.
131. Moon H.E., Cheon H., Chun K.H., Lee S.K., Kim Y.S., Jung B.K., et al. Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha. Oncology Reports 2006, 16:929-935.
132. Moon H.E., Cheon H., Lee M.S. Metastasis-associated protein 1 inhibits p53-induced apoptosis. Oncology Reports 2007, 18:1311-1314.
133. Nagaraj S.R., Shilpa P., Rachaiah K., Salimath B.P. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma. Molecular Carcinogenesis 2013, 54:333-350. 10.1002/mc.22104.
134. Nair S.S., Li D.Q., Kumar R. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Molecular Cell 2013, 49:704-718.
135. Nguyen D.X., Bos P.D., Massague J. Metastasis: From dissemination to organ-specific colonization. Nature Reviews Cancer 2009, 9:274-284.
136. Norris A., Bianchet M.A., Boeke J.D. Compensatory interactions between Sir3p and the nucleosomal LRS surface imply their direct interaction. PLoS Genetics 2008, 4:e1000301.
137. Nowak A.J., Alfieri C., Stirnimann C.U., Rybin V., Baudin F., Ly-Hartig N., et al. Chromatin-modifying complex component Nurf55/p55 associates with histones H3 and H4 and polycomb repressive complex 2 subunit Su(z)12 through partially overlapping binding sites. The Journal of Biological Chemistry 2011, 286:23388-23396.
138. Ohshiro K., Rayala S.K., Wigerup C., Pakala S.B., Natha R.S., Gururaj A.E., et al. Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator. EMBO Reports 2010, 11:691-697.
139. Onishi M., Liou G.G., Buchberger J.R., Walz T., Moazed D. Role of the conserved Sir3-BAH domain in nucleosome binding and silent chromatin assembly. Molecular Cell 2007, 28:1015-1028.
140. Pakala S.B., Bui-Nguyen T.M., Reddy S.D., Li D.Q., Peng S., Rayala S.K., et al. Regulation of NF-kappaB circuitry by a component of the nucleosome remodeling and deacetylase complex controls inflammatory response homeostasis. The Journal of Biological Chemistry 2010, 285:23590-23597.
141. Pakala S.B., Rayala S.K., Wang R.A., Ohshiro K., Mudvari P., Reddy S.D., et al. MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer. Cancer Research 2013, 73:3761-3770.
142. Pakala S.B., Reddy S.D., Bui-Nguyen T.M., Rangparia S.S., Bommana A., Kumar R. MTA1 coregulator regulates LPS response via MyD88-dependent signaling. The Journal of Biological Chemistry 2010, 285:32787-32792.
143. Pakala S.B., Singh K., Reddy S.D., Ohshiro K., Li D.Q., Mishra L., et al. TGF-beta1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene 2011, 30:2230-2241.
144. Park H.R., Cabrini R.L., Araujo E.S., Paparella M.L., Brandizzi D., Park Y.K. Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw. Tumori 2009, 95:81-86.
145. Park H.R., Jung W.W., Kim H.S., Bacchini P., Bertoni F., Park Y.K. Overexpression of metastatic tumor antigen in osteosarcoma: Comparison between conventional high-grade and central low-grade osteosarcoma. Cancer Research and Treatment: Official Journal of Korean Cancer Association 2005, 37:360-364.
146. Park J.O., Jung C.K., Sun D.I., Joo Y.H., Kim M.S. Relationships between metastasis-associated protein (MTA) 1 and lymphatic metastasis in tonsil cancer. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies 2011, 268:1329-1334.
147. Park Y.H., Shin H.J., Kim S.U., Kim J.M., Kim J.H., Bang D.H., et al. iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation. Biochemical and Biophysical Research Communications 2013, 435:244-249.
148. Prisco M.G., Zannoni G.F., De Stefano I., Vellone V.G., Tortorella L., Fagotti A., et al. Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: A clinical study. Human Pathology 2012, 43:282-288.
149. Psaila B., Lyden D. The metastatic niche: Adapting the foreign soil. Nature Reviews Cancer 2009, 9:285-293.
150. Qian H., Lu N., Xue L., Liang X., Zhang X., Fu M., et al. Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clinical & Experimental Metastasis 2005, 22:653-662.
151. Reddy S.D., Pakala S.B., Molli P.R., Sahni N., Karanam N.K., Mudvari P., et al. Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function. The Journal of Biological Chemistry 2012, 287:27843-27850.
152. Reddy S.D., Pakala S.B., Ohshiro K., Rayala S.K., Kumar R. MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Research 2009, 69:5639-5642.
153. Reddy S.D., Rayala S.K., Ohshiro K., Pakala S.B., Kobori N., Dash P., et al. Multiple coregulatory control of tyrosine hydroxylase gene transcription. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:4200-4205.
154. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nature Reviews. Molecular Cell Biology 2008, 9:402-412.
155. Roberts C.W., Orkin S.H. The SWI/SNF complex-Chromatin and cancer. Nature Reviews Cancer 2004, 4:133-142.
156. Roepman P., de Jager A., Groot Koerkamp M.J., Kummer J.A., Slootweg P.J., Holstege F.C. Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Research 2006, 66:11110-11114.
157. Ryu S.H., Chung Y.H., Lee H., Kim J.A., Shin H.D., Min H.J., et al. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 2008, 47:929-936.
158. Safe S., Abdelrahim M. Sp transcription factor family and its role in cancer. European Journal of Cancer 2005, 41:2438-2448.
159. Salot S., Gude R. MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines. European Journal of Cancer 2013, 49:492-499.
160. Sasaki H., Moriyama S., Nakashima Y., Kobayashi Y., Yukiue H., Kaji M., et al. Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer 2002, 35:149-154.
161. Sasaki H., Yukiue H., Kobayashi Y., Nakashima Y., Kaji M., Fukai I., et al. Expression of the MTA1 mRNA in thymoma patients. Cancer Letters 2001, 174:159-163.
162. Semenza G.L. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer 2003, 3:721-732.
163. Sen N., Gui B., Kumar R. Role of MTA1 in cancer progression and metastasis. Cancer Metastasis Reviews 2014, 33:879-889.
164. Sen N., Gui B., Kumar R. Physiological functions of MTA family of proteins. Cancer and Metastasis Reviews 2014, 33:869-877.
165. Shen W.H., Balajee A.S., Wang J., Wu H., Eng C., Pandolfi P.P., et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007, 128:157-170.
166. Sherr C.J. The INK4a/ARF network in tumour suppression. Nature Reviews. Molecular Cell Biology 2001, 2:731-737.
167. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 2014, 64:9-29.
168. Simpson A., Uitto J., Rodeck U., Mahoney M.G. Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3. Gene 2001, 273:29-39.
169. Singh R.R., Barnes C.J., Talukder A.H., Fuqua S.A., Kumar R. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Research 2005, 65:10594-10601.
170. Song Q., Li Y., Zheng X., Fang Y., Chao Y., Yao K., et al. MTA1 contributes to actin cytoskeleton reorganization and metastasis of nasopharyngeal carcinoma by modulating Rho GTPases and Hedgehog signaling. The International Journal of Biochemistry & Cell Biology 2013, 45:1439-1446.
171. Song H., Spichiger-Haeusermann C., Basler K. The ISWI-containing NURF complex regulates the output of the canonical Wingless pathway. EMBO Reports 2009, 10:1140-1146.
172. Song L., Wang Z., Liu X. MTA1: A prognosis indicator of postoperative patients with esophageal carcinoma. The Thoracic and Cardiovascular Surgeon 2012, 61:479-485.
173. Song Q., Zhang H., Wang M., Song W., Ying M., Fang Y., et al. MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo. Journal of Experimental & Clinical Cancer Research: CR 2013, 32:54.
174. Talukder A.H., Gururaj A., Mishra S.K., Vadlamudi R.K., Kumar R. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator. Molecular and Cellular Biology 2004, 24:6581-6591.
175. Talukder A.H., Mishra S.K., Mandal M., Balasenthil S., Mehta S., Sahin A.A., et al. MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. The Journal of Biological Chemistry 2003, 278:11676-11685.
176. Tessarz P., Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nature Reviews. Molecular Cell Biology 2014, 15:703-708.
177. Thomas C., Gustafsson J.A. The different roles of ER subtypes in cancer biology and therapy. Nature Reviews Cancer 2011, 11:597-608.
178. Toh Y., Kuwano H., Mori M., Nicolson G.L., Sugimachi K. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. British Journal of Cancer 1999, 79:1723-1726.
179. Toh Y., Nicolson G.L. The role of the MTA family and their encoded proteins in human cancers: Molecular functions and clinical implications. Clinical & Experimental Metastasis 2009, 26:215-227.
180. Toh Y., Nicolson G.L. Properties and clinical relevance of MTA1 protein in human cancer. Cancer Metastasis Reviews 2014, 33:891-900.
181. Toh Y., Ohga T., Endo K., Adachi E., Kusumoto H., Haraguchi M., et al. Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. International Journal of Cancer. Journal International du Cancer 2004, 110:362-367.
182. Toh Y., Oki E., Oda S., Tokunaga E., Ohno S., Maehara Y., et al. Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis. International Journal of Cancer. Journal International du Cancer 1997, 74:459-463.
183. Toh Y., Pencil S.D., Nicolson G.L. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. The Journal of Biological Chemistry 1994, 269:22958-22963.
184. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 1998, 395:917-921.
185. Trepo C., Chan H.L., Lok A. Hepatitis B virus infection. Lancet 2014, 384:2053-2063.
186. Tsukiyama T., Daniel C., Tamkun J., Wu C. ISWI, a member of the SWI2/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell 1995, 83:1021-1026.
187. Tsukiyama T., Wu C. Purification and properties of an ATP-dependent nucleosome remodeling factor. Cell 1995, 83:1011-1020.
188. Tuncay Cagatay S., Cimen I., Savas B., Banerjee S. MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells. Tumour Biology 2013, 34(2):1189-1204. 10.1007/s13277-013-0662-x.
189. Uraki S., Sugimoto K., Shiraki K., Tameda M., Inagaki Y., Ogura S., et al. Human beta-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression. International Journal of Oncology 2014, 45:1059-1064.
190. van Riggelen J., Yetil A., Felsher D.W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nature Reviews Cancer 2010, 10:301-309.
191. Voss T.C., Hager G.L. Dynamic regulation of transcriptional states by chromatin and transcription factors. Nature Reviews Genetics 2014, 15:69-81.
192. Wade P.A., Jones P.L., Vermaak D., Wolffe A.P. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Current Biology: CB 1998, 8:843-846.
193. Wang R.A. MTA1-a stress response protein: A master regulator of gene expression and cancer cell behavior. Cancer Metastasis Reviews 2014, 33:1001-1009.
194. Wang L., Charroux B., Kerridge S., Tsai C.C. Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates. EMBO Reports 2008, 9:555-562.
195. Wang H., Fan L., Wei J., Weng Y., Zhou L., Shi Y., et al. Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells. PloS One 2012, 7:e46888.
196. Wang Y., Li L., Li Q., Xie C., Wang E. Expression of P120 catenin, Kaiso, and metastasis tumor antigen-2 in thymomas. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 2012, 33:1871-1879.
197. Wang Y., Zhang H., Chen Y., Sun Y., Yang F., Yu W., et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009, 138:660-672.
198. Weng W., Yin J., Zhang Y., Qiu J., Wang X. Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin. International Journal of Oncology 2014, 44:812-818.
199. Wilson B.G., Roberts C.W. SWI/SNF nucleosome remodellers and cancer. Nature Reviews Cancer 2011, 11:481-492.
200. Wouters B.G., Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nature Reviews Cancer 2008, 8:851-864.
201. Xia Y., Chen Q., Zhong Z., Xu C., Wu C., Liu B., et al. Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 2013, 32:476-485.
202. Xia L., Zhang Y. Sp1 and ETS family transcription factors regulate the mouse Mta2 gene expression. Gene 2001, 268:77-85.
203. Xiao H., Sandaltzopoulos R., Wang H.M., Hamiche A., Ranallo R., Lee K.M., et al. Dual functions of largest NURF subunit NURF301 in nucleosome sliding and transcription factor interactions. Molecular Cell 2001, 8:531-543.
204. Xu L., Mao X.Y., Fan C.F., Zheng H.C. MTA1 expression correlates significantly with cigarette smoke in non-small cell lung cancer. Virchows Archiv: An International Journal of Pathology 2011, 459:415-422.
205. Xue Y., Wong J., Moreno G.T., Young M.K., Cote J., Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Molecular Cell 1998, 2:851-861.
206. Yan D., Avtanski D., Saxena N.K., Sharma D. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. The Journal of Biological Chemistry 2012, 287:8598-8612.
207. Yan C., Wang H., Toh Y., Boyd D.D. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. The Journal of Biological Chemistry 2003, 278:2309-2316.
208. Yang Q.Y., Li J.H., Wang Q.Y., Wu Y., Qin J.L., Cheng J.J., et al. MTA1 promotes cell proliferation via DNA damage repair in epithelial ovarian cancer. Genetics and Molecular Research: GMR 2014, 13:10269-10278.
209. Yang N., Xu R.M. Structure and function of the BAH domain in chromatin biology. Critical Reviews in Biochemistry and Molecular Biology 2013, 48:211-221.
210. Yao Y.L., Yang W.M. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. The Journal of Biological Chemistry 2003, 278:42560-42568.
211. Yoo Y.G., Kong G., Lee M.O. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. The EMBO Journal 2006, 25:1231-1241.
212. Yoo Y.G., Na T.Y., Seo H.W., Seong J.K., Park C.K., Shin Y.K., et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008, 27:3405-3413.
213. Yu L., Su Y.S., Zhao J., Wang H., Li W. Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells. FEBS Letters 2013, 587:2542-2551.
214. Yu Y., Wang Z., Zhang M.Y., Liu X.Y., Zhang H. Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer. Interactive Cardiovascular and Thoracic Surgery 2011, 12:166-169.
215. Yuan T., Zhang H., Liu B., Zhang Q., Liang Y., Zheng R., et al. Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis. Medical Oncology 2014, 31:330.
216. Zhang L., Chen Q.Y., Liu H., Tang L.Q., Mai H.Q. Emerging treatment options for nasopharyngeal carcinoma. Drug Design, Development and Therapy 2013, 7:37-52.
217. Zhang X.Y., DeSalle L.M., Patel J.H., Capobianco A.J., Yu D., Thomas-Tikhonenko A., et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13968-13973.
218. Zhang Y., LeRoy G., Seelig H.P., Lane W.S., Reinberg D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998, 95:279-289.
219. Zhang Y., Ng H.H., Erdjument-Bromage H., Tempst P., Bird A., Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes & Development 1999, 13:1924-1935.
220. Zhang H., Stephens L.C., Kumar R. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2006, 12:1479-1486.
221. Zhang X., Zhang Y., Li Y. beta-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells. Oncology Reports 2013, 30:745-750.
222. Zhao L., Liu L., Wang S., Zhang Y.F., Yu L., Ding Y.Q. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. Journal of Cancer Research and Clinical Oncology 2007, 133:771-782.
223. Zheng S., Du Y., Chu H., Chen X., Li P., Wang Y., et al. Analysis of MAT3 gene expression in NSCLC. Diagnostic Pathology 2013, 8:166.
224. Zhou C., Ji J., Cai Q., Shi M., Chen X., Yu Y., et al. MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1. Molecular Cancer 2013, 12:102.
225. Zhou H., Xu X., Xun Q., Yu D., Ling J., Guo F., et al. microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. Oncology Reports 2012, 27:807-812.
226. Zhou J., Zhan S., Tan W., Cheng R., Gong H., Zhu Q. P300 binds to and acetylates MTA2 to promote colorectal cancer cells growth. Biochemical and Biophysical Research Communications 2014, 444:387-390.
227. Zhu W., Cai M.Y., Tong Z.T., Dong S.S., Mai S.J., Liao Y.J., et al. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut 2012, 61:562-575.
228. Zhu X., Guo Y., Li X., Ding Y., Chen L. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2010, 5:1159-1166.